Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Inflamm Intest Dis. 2017 Nov 18;2(3):147–153. doi: 10.1159/000484347

Table 3. Odds of medication use adjusting for age, sex, disease duration, aggressive disease and type of inflammatory bowel disease.

Asian (ref: white) Odds Ratio 95% Confidence Interval
Thiopurines 0.78 0.53-1.15
Biologic agents* 0.45 0.30-0.67
Narcotics 0.47 0.30-0.74

Aggressive disease is defined as stricturing or penetrating disease for Crohn's disease and pancolitis for ulcerative colitis

*

Biologic agents include infliximab, adalimumab, certolizumab, golimumab, vedolizumab and ustekinumab